首页|宣通方调节单胺类神经递质和氧化应激改善卒中后抑郁的研究

宣通方调节单胺类神经递质和氧化应激改善卒中后抑郁的研究

扫码查看
目的 探讨宣通方的活性成分及其对卒中后抑郁(PSD)大鼠的治疗作用及机制.方法 采用超高效液相色谱-四极杆飞行时间串联质谱(UPLC-Q-TOF-MS)技术鉴定宣通方活性成分.基于所鉴定的成分,通过网络药理学分析预测宣通方治疗PSD的潜在作用机制.体内构建PSD大鼠模型,通过行为学实验、病理组织染色探究宣通方对PSD大鼠的药效学作用.通过ELISA检测宣通方对PSD大鼠单胺类神经递质和氧化应激水平的影响.结果 UPLC-Q-TOF-MS筛选得到宣通方活性成分57个,网络药理学分析得到宣通方潜在作用靶点734个,与PSD疾病相关靶点的共有靶点562个.共有靶点主要富集在单胺类神经递质通路、氧化应激反应等过程.体内实验结果表明,与模型组相比,艾司西酞普兰组和宣通方高剂量组大鼠糖水偏好程度明显增加(P<0.01,P<0.05),旷场实验活动次数明显增加(P<0.01,P<0.05),悬尾不动时间明显减少(P<0.05,P<0.01),强迫游泳不动时间明显减少(P<0.05,P<0.05);各给药组大鼠的海马组织排列相对整齐,病理改变明显减轻,神经细胞的数量增加,Nissl 阳性细胞数较模型组增多;宣通方高剂量组大鼠血清中单胺类神经递质5-HT水平明显上升(P<0.05),DA水平明显上升(P<0.01,P<0.05),抗氧化酶SOD水平明显上升(P<0.01,P<0.05),CAT水平显著上升(P<0.01),脂质过氧化物MDA水平显著下降(P<0.01).结论 宣通方可通过调控单胺类神经递质和氧化应激发挥治疗PSD的作用.
Xuantong prescription improves post-stroke depression via regulating monoamine neurotransmitter and oxidative stress
Objective To explore the active components of Xuantong prescription and its mechanism in the treatment of post-stroke depression(PSD)rats.Methods UPLC-Q-TOF-MS technology was used to identify the active components of Xuantong prescription.Based on the identified components,the potential mechanism of Xuantong prescription in the treatment of PSD was predicted by network pharmacological analysis.The PSD rat model was constructed,and the pharmacodynamic effect of Xuantong prescription on PSD rats was explored by behavioral experiments and pathological tissue staining,and the effects of Xuantong prescription on monoamine neurotransmitters and oxidative stress levels in PSD rats were detected by ELISA.Results Totally 57 active components of Xuantong prescription,734 potential targets,and 562 intersected with PSD-related targets were obtained.Common targets were mainly enriched in monoamine neurotransmitter pathways,oxidative stress responses and other processes.The in vivo experimental results indicated that compared with the model group,the sucrose preference rate of rats in the escitalopram group and high-dose Xuantong prescription group significantly increased(P<0.01,P<0.05),the number of open field test activities significantly increased(P<0.01,P<0.05),the tail suspension time significantly decreased(P<0.05,P<0.01),and the forced swimming immobility time significantly decreased(P<0.05).In each administration group,the arrangement of hippocampal tissue was relatively orderly,pathological changes were obviously mitigated,and the number of neurons and Nissl-positive cells were higher when compared to the model group.In the group of rats treated with high-dose Xuantong prescription,there was a significant increase in serum levels of 5-HT(P<0.05),DA(P<0.01,P<0.05),antioxidant enzyme SOD(P<0.01,P<0.05),and CAT(P<0.01),along with a significant decrease in lipid peroxide MDA levels(P<0.01).Conclusion Xuantong prescription can play a role in the treatment of PSD by regulating monoamine neurotransmitters and oxidative stress.

Xuantong prescriptionpost-stroke depression(PSD)UPLC-Q-TOF-MSnetwork pharmacologymonoaminergic neurotransmittersoxidative stress

任凌志、温钰鹏、徐诗画、李雁扬、王一、吴叶群、于洋、宁为民、谭静

展开 >

广州中医药大学,广东 广州 510006

广州中医药大学东莞医院,广东 东莞 523000

宣通方 卒中后抑郁 超高效液相色谱-四极杆飞行时间串联质谱 网络药理学 单胺类神经递质 氧化应激

2024

广东药科大学学报
广东药学院

广东药科大学学报

CSTPCD
影响因子:0.698
ISSN:1006-8783
年,卷(期):2024.40(4)